$OMER
OMEROS CORP Stock $omer

$omer Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924010416 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$12.26M	$10.88M	$49.66M
YoY Change	10.46%	-19.97%	-1.99%
% of Gross Profit
Research & Development	$26.77M	$28.89M	$114.9M
YoY Change	8.78%	8.82%	1.91%
% of Gross Profit
Depreciation & Amortization	$204.0K	$205.0K	$920.0K
YoY Change	9.68%	25.77%	-3.36%
% of Gross Profit
Operating Expenses	$39.03M	$39.77M	$164.5M
YoY Change	58.61%	-0.93%	45.96%
Operating Profit	-$39.03M		-$164.5M
YoY Change	9.3%		0.7%
Interest Expense	$8.231M	-$7.063M	$30.84M
YoY Change	3.76%	-10.63%	35.86%
% of Operating Profit
Other Income/Expense, Net	$3.415M	$3.429M	$16.34M
YoY Change	-13.83%	72.05%	302.31%
Pretax Income	-$43.85M	-$39.29M	-$174.9M
YoY Change	10.5%	-14.68%	-3.91%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$37.18M	-$9.068M	-$117.8M
YoY Change	10.34%	-107.04%	-348.52%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.63		-$1.88
Diluted Earnings Per Share	-$0.63	-$0.14	-$1.87
COMMON SHARES
Basic Shares Outstanding	57.94M	62.87M	62.74M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$230.3M	$171.9M	$171.8M
YoY Change	-38.01%	-11.83%	-11.84%
Cash & Equivalents	$1.831M	$7.105M	$7.105M
Short-Term Investments	$228.5M	$164.8M	$164.7M
Other Short-Term Assets	$13.46M	$8.581M	$8.581M
YoY Change	100.7%	36.21%	36.21%
Inventory
Prepaid Expenses
Receivables	$36.51M	$36.10M	$36.10M
Other Receivables	$656.0K	$1.372M	$1.372M
Total Short-Term Assets	$281.0M	$217.9M	$217.9M
YoY Change	-32.63%	-50.84%	-50.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.804M	$1.950M	$20.58M
YoY Change	-91.93%	-91.61%	-11.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.054M	$1.054M	$1.054M
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$156.5M	$160.4M	$160.4M
YoY Change	9.39%	8.55%	8.55%
TOTAL ASSETS
Total Short-Term Assets	$281.0M	$217.9M	$217.9M
Total Long-Term Assets	$156.5M	$160.4M	$160.4M
Total Assets	$437.5M	$378.3M	$378.3M
YoY Change	-21.89%	-35.99%	-35.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.182M	$7.712M	$7.712M
YoY Change	-4.1%	28.77%	28.77%
Accrued Expenses	$28.40M	$31.87M	$36.46M
YoY Change	-7.85%	4.31%	5.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$19.13M	$8.576M	$9.146M
YoY Change	-80.38%	-91.06%	-90.47%
Total Short-Term Liabilities	$59.06M	$53.32M	$53.32M
YoY Change	-57.57%	-60.91%	-60.91%
LONG-TERM LIABILITIES
Long-Term Debt	$430.9M	$329.7M	$330.4M
YoY Change	25.17%	-4.84%	-4.64%
Other Long-Term Liabilities	$18.84M	$20.23M	$19.51M
YoY Change	-13.33%	-9.74%	-12.95%
Total Long-Term Liabilities	$449.8M	$349.9M	$349.9M
YoY Change	22.88%	-5.14%	-5.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$59.06M	$53.32M	$53.32M
Total Long-Term Liabilities	$449.8M	$349.9M	$349.9M
Total Liabilities	$508.8M	$403.3M	$403.3M
YoY Change	0.72%	-20.19%	-20.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$790.7M	-$753.5M
YoY Change	18.12%	18.53%
Common Stock	$719.4M	$728.5M
YoY Change	-0.69%	0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$71.33M	-$24.98M	-$24.98M
YoY Change
Total Liabilities & Shareholders Equity	$437.5M	$378.3M	$378.3M
YoY Change	-21.89%	-35.99%	-35.99%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$37.18M	-$9.068M	-$117.8M
YoY Change	10.34%	-107.04%	-348.52%
Depreciation, Depletion And Amortization	$204.0K	$205.0K	$920.0K
YoY Change	9.68%	25.77%	-3.36%
Cash From Operating Activities	-$41.80M	-$34.83M	$74.70M
YoY Change	-123.95%	37.2%	-186.36%
INVESTING ACTIVITIES
Capital Expenditures	$58.00K	$118.0K	$426.0K
YoY Change		807.69%	276.99%
Acquisitions
YoY Change
Other Investing Activities	-$61.87M	$116.4M	$27.88M
YoY Change	-65.88%	-207.27%	-121.88%
Cash From Investing Activities	-$61.93M	$116.2M	$27.45M
YoY Change	-65.85%	-207.15%	-121.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$4.654M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$98.43M	-105.0M	-$106.1M
YoY Change	-25468.81%	16021.81%	-185.38%
NET CHANGE
Cash From Operating Activities	-$41.80M	-34.83M	$74.70M
Cash From Investing Activities	-$61.93M	116.2M	$27.45M
Cash From Financing Activities	$98.43M	-105.0M	-$106.1M
Net Change In Cash	-$5.274M	-23.54M	-$3.904M
YoY Change	-26.55%	-82.5%	-95.65%
FREE CASH FLOW
Cash From Operating Activities	-$41.80M	-$34.83M	$74.70M
Capital Expenditures	$58.00K	$118.0K	$426.0K
Free Cash Flow	-$41.86M	-$34.94M	$74.27M
YoY Change	-123.99%	37.6%	-185.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61128597
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61128597
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62828765
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62828765
CY2023	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-15315000	usd
CY2021Q4	omer	Milestone Period MilestonePeriod	P4Y
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2023Q4	omer	Number Of Options To Extend Lease Term NumberOfOptionsToExtendLeaseTerm	2	pure
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-34475
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WA
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1663741
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	201 Elliott Avenue West
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98119
CY2023	dei	City Area Code CityAreaCode	206
CY2023	dei	Local Phone Number LocalPhoneNumber	676-5000
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	OMER
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	328153747	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57942695
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	Seattle, Washington
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7105000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11009000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	164743000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	183909000	usd
CY2023Q4	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29373000	usd
CY2022Q4	omer	Royalty Receivable Current RoyaltyReceivableCurrent	28797000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8096000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	213221000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8581000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6300000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	217898000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	443236000	usd
CY2023Q4	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	138736000	usd
CY2022Q4	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	123425000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18631000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21762000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1950000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1492000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1054000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1054000	usd
CY2023Q4	us-gaap	Assets Assets	378269000	usd
CY2022Q4	us-gaap	Assets Assets	590969000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7712000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5989000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31868000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30551000	usd
CY2023Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	0	usd
CY2022Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	94381000	usd
CY2023Q4	omer	Royalty Obligation Current RoyaltyObligationCurrent	8576000	usd
CY2022Q4	omer	Royalty Obligation Current RoyaltyObligationCurrent	1152000	usd
CY2023Q4	omer	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5160000	usd
CY2022Q4	omer	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	4310000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	53316000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	136383000	usd
CY2023Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	213155000	usd
CY2022Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	220906000	usd
CY2023Q4	omer	Royalty Liabilities Noncurrent RoyaltyLiabilitiesNoncurrent	116550000	usd
CY2022Q4	omer	Royalty Liabilities Noncurrent RoyaltyLiabilitiesNoncurrent	125126000	usd
CY2023Q4	omer	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	18143000	usd
CY2022Q4	omer	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	22426000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2088000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	444000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	611000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	628000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	727936000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	720773000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-753530000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-635717000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24983000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	85684000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	378269000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	590969000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	114870000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	112721000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	118775000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49660000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50668000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	54842000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	164530000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	163389000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	173617000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-164530000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-163389000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-173617000	usd
CY2023	us-gaap	Interest Expense InterestExpense	30844000	usd
CY2022	us-gaap	Interest Expense InterestExpense	22702000	usd
CY2021	us-gaap	Interest Expense InterestExpense	19669000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	16342000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	4062000	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	1740000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4112000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-174920000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-182029000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-191546000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	57107000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	229446000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	385781000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-117813000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	47417000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	194235000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.79
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.9
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-3.07
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.91
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	3.66
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	6.19
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.88
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.12
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62739227
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62737091
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62344100
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-120752000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8382000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	91000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	241000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	17539000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	194235000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23780000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	415000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	14072000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	47417000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	85684000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	150000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4654000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	11650000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-117813000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24983000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-117813000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	47417000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	194235000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	11650000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	14072000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	17630000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1853000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1830000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1696000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	920000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	952000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1386000	usd
CY2023	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	41167000	usd
CY2022	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	14457000	usd
CY2021	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	-0	usd
CY2022	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-18634000	usd
CY2021	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	0	usd
CY2023	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	8714000	usd
CY2022	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-0	usd
CY2021	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4112000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-0	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	310563000	usd
CY2023	omer	Non Cash Interest Expense On Royalty Obligation NonCashInterestExpenseOnRoyaltyObligation	0	usd
CY2022	omer	Non Cash Interest Expense On Royalty Obligation NonCashInterestExpenseOnRoyaltyObligation	1695000	usd
CY2021	omer	Non Cash Interest Expense On Royalty Obligation NonCashInterestExpenseOnRoyaltyObligation	0	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-205125000	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	175066000	usd
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	34314000	usd
CY2023	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-40595000	usd
CY2022	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-65439000	usd
CY2021	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-0	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4682000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10665000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14640000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2978000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-934000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5568000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	74726000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-86483000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-109722000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1018602000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	429045000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	32006000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1046482000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	301594000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	100000000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	426000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	113000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	277000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	125993000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27454000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-127564000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	193710000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	99873000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4654000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2023	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	1152000	usd
CY2022	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	417000	usd
CY2021	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	-0	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	555000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	750000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1823000	usd
CY2023	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	150000	usd
CY2022	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	415000	usd
CY2021	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	8383000	usd
CY2023	omer	Proceeds From Royalty Obligation ProceedsFromRoyaltyObligation	0	usd
CY2022	omer	Proceeds From Royalty Obligation ProceedsFromRoyaltyObligation	125000000	usd
CY2021	omer	Proceeds From Royalty Obligation ProceedsFromRoyaltyObligation	0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	241000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-106084000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	124248000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6319000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3904000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-89799000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	90307000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11009000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	100808000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10501000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7105000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11009000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	100808000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	29923000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	19178000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	17876000	usd
CY2023	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	952000	usd
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	40000	usd
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	289000	usd
CY2021Q4	omer	Milestone Payment If Achieved Under Asset Purchase Agreement MilestonePaymentIfAchievedUnderAssetPurchaseAgreement	200000000	usd
CY2022Q4	omer	Milestone Payment Receivable MilestonePaymentReceivable	200000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	171800000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	74700000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-117800000	usd
CY2023	omer	Cash Proceeds From Milestone Payment CashProceedsFromMilestonePayment	200000000	usd
CY2023Q4	omer	Equity Offering Facility Maximum Aggregate Offering Amount EquityOfferingFacilityMaximumAggregateOfferingAmount	150000000	usd
CY2021Q4	omer	Percentage Of Royalty Receivable On Sale Of Product Rights PercentageOfRoyaltyReceivableOnSaleOfProductRights	0.50	pure
CY2022Q4	omer	Percentage Of Royalty Receivable On Sale Of Product Rights PercentageOfRoyaltyReceivableOnSaleOfProductRights	0.30	pure
CY2022Q4	omer	Milestone Payment Receivable MilestonePaymentReceivable	200000000	usd
CY2022Q4	omer	Percentage Of Royalty Receivable On Sale Of Product Rights PercentageOfRoyaltyReceivableOnSaleOfProductRights	0.30	pure
CY2022Q4	omer	Percentage Of Royalty Receivable On Sale Of Product Rights PercentageOfRoyaltyReceivableOnSaleOfProductRights	0.30	pure
CY2023Q1	omer	Percentage Of Interest Earned On Outstanding Contract Royalty Asset PercentageOfInterestEarnedOnOutstandingContractRoyaltyAsset	0.11	pure
CY2023	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	800000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 11pt;"><i>Financial Instruments and Concentrations of Credit Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;">Cash and cash equivalents, receivables, accounts payable and accrued liabilities, which are recorded at invoiced amount or cost, approximate fair value based on the short-term nature of these financial instruments. The fair value of short-term investments is based on quoted market prices. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and receivables. Cash and cash equivalents are held by financial institutions and are federally insured up to certain limits. At times, our cash and cash equivalents balance held at a financial institution <em style="font: inherit;"> may </em>exceeds the federally insured limits. To limit the credit risk, we invest our excess cash in high-quality securities such as money market mutual funds, certificates of deposit and U.S. treasury bills.</p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15489772
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17221985
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18823760
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	14700000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2200000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	164743000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	19000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	164762000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	165797000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	19000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	165816000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	183909000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	22000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	183931000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	184963000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	22000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	184985000	usd
CY2023Q4	omer	Milestone Payment Receivable MilestonePaymentReceivable	0	usd
CY2022Q4	omer	Milestone Payment Receivable MilestonePaymentReceivable	200000000	usd
CY2023Q4	omer	Royalty Receivable RoyaltyReceivable	6724000	usd
CY2022Q4	omer	Royalty Receivable RoyaltyReceivable	12966000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1372000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	255000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8096000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	213221000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12191000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11040000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10241000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9548000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1950000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1492000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	900000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1400000	usd
CY2023Q4	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	10168000	usd
CY2022Q4	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	5536000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7380000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6665000	usd
CY2023Q4	omer	Accrued Contract Research Costs AccruedContractResearchCosts	6223000	usd
CY2022Q4	omer	Accrued Contract Research Costs AccruedContractResearchCosts	3209000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4242000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5172000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3539000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4425000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	316000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5544000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31868000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	30551000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	215924000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2769000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	213155000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	320030000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4743000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	315287000	usd
CY2022Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures		usd
CY2023Q4	omer	Royalty Obligation Interest Payments Due Year Five RoyaltyObligationInterestPaymentsDueYearFive	5598000	usd
CY2023Q4	omer	Royalty Obligation Payments Due Year Five RoyaltyObligationPaymentsDueYearFive	25000000	usd
CY2023Q4	omer	Royalty Obligation Principal Payments Due After Year Five RoyaltyObligationPrincipalPaymentsDueAfterYearFive	48762000	usd
CY2023Q4	omer	Royalty Obligation Interest Payments Due After Year Five RoyaltyObligationInterestPaymentsDueAfterYearFive	4988000	usd
CY2022Q4	omer	Royalty Obligations RoyaltyObligations	126278000	usd
CY2023	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	1152000	usd
CY2023Q4	omer	Royalty Obligations RoyaltyObligations	125126000	usd
CY2023Q4	omer	Royalty Obligation Principal Payments Due Next Twelve Months RoyaltyObligationPrincipalPaymentsDueNextTwelveMonths	8576000	usd
CY2023Q4	omer	Royalty Obligation Interest Payments Due Next Twelve Months RoyaltyObligationInterestPaymentsDueNextTwelveMonths	11424000	usd
CY2023Q4	omer	Royalty Obligation Payments Due Next Twelve Months RoyaltyObligationPaymentsDueNextTwelveMonths	20000000	usd
CY2023Q4	omer	Royalty Obligation Principal Payments Due Year Two RoyaltyObligationPrincipalPaymentsDueYearTwo	14641000	usd
CY2023Q4	omer	Royalty Obligation Interest Payments Due Year Two RoyaltyObligationInterestPaymentsDueYearTwo	10359000	usd
CY2023Q4	omer	Royalty Obligation Payments Due Year Two RoyaltyObligationPaymentsDueYearTwo	25000000	usd
CY2023Q4	omer	Royalty Obligation Principal Payments Due Year Three RoyaltyObligationPrincipalPaymentsDueYearThree	16081000	usd
CY2023Q4	omer	Royalty Obligation Interest Payments Due Year Three RoyaltyObligationInterestPaymentsDueYearThree	8919000	usd
CY2023Q4	omer	Royalty Obligation Payments Due Year Three RoyaltyObligationPaymentsDueYearThree	25000000	usd
CY2023Q4	omer	Royalty Obligation Principal Payments Due Year Four RoyaltyObligationPrincipalPaymentsDueYearFour	17664000	usd
CY2023Q4	omer	Royalty Obligation Interest Payments Due Year Four RoyaltyObligationInterestPaymentsDueYearFour	7336000	usd
CY2023Q4	omer	Royalty Obligation Payments Due Year Four RoyaltyObligationPaymentsDueYearFour	25000000	usd
CY2023Q4	omer	Royalty Obligation Principal Payments Due Year Five RoyaltyObligationPrincipalPaymentsDueYearFive	19402000	usd
CY2023Q4	omer	Royalty Obligation Payments Due After Year Five RoyaltyObligationPaymentsDueAfterYearFive	53750000	usd
CY2023Q4	omer	Royalty Obligation Principal Payments Due RoyaltyObligationPrincipalPaymentsDue	125126000	usd
CY2023Q4	omer	Royalty Obligation Interest Payments Due RoyaltyObligationInterestPaymentsDue	48624000	usd
CY2023Q4	omer	Royalty Obligation Payments Due RoyaltyObligationPaymentsDue	173750000	usd
CY2023Q4	omer	Rightofuse Assets From Leases RightofuseAssetsFromLeases	19851000	usd
CY2022Q4	omer	Rightofuse Assets From Leases RightofuseAssetsFromLeases	22707000	usd
CY2023Q4	omer	Lease Liability LeaseLiability	23303000	usd
CY2022Q4	omer	Lease Liability LeaseLiability	26736000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1281	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1281	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0857	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1044	pure
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	6464000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	6152000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	677000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	812000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	174000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	174000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	3160000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	3191000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	1500000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	1755000	usd
CY2023	us-gaap	Lease Cost LeaseCost	8975000	usd
CY2022	us-gaap	Lease Cost LeaseCost	8574000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	7144000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	7072000	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	655000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	790000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8528000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	684000	usd
CY2023Q4	omer	Lessee Operating And Finance Lease Liability Payments Due Next Twelve Months LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths	9212000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7088000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	517000	usd
CY2023Q4	omer	Lessee Operating And Finance Lease Liability Payments Due Year Two LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	7605000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6870000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	258000	usd
CY2023Q4	omer	Lessee Operating And Finance Lease Liability Payments Due Year Three LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	7128000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5950000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q4	omer	Lessee Operating And Finance Lease Liability Payments Due Year Four LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	5950000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	28436000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1459000	usd
CY2023Q4	omer	Lessee Operating And Finance Lease Liability Payments Due LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue	29895000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6422000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	170000	usd
CY2023Q4	omer	Lessee Operating And Finance Lease Liability Undiscounted Excess Amount LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount	6592000	usd
CY2023Q4	omer	Lease Liability LeaseLiability	23303000	usd
CY2023Q4	omer	Longterm Purchase Commitment Termination Fee LongtermPurchaseCommitmentTerminationFee	25800000	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	24057403
CY2021Q1	omer	Equity Offering Facility Maximum Aggregate Offering Amount EquityOfferingFacilityMaximumAggregateOfferingAmount	150000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11650000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14072000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17630000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13872973
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.02
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3153200
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.01
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	36726
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1734293
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.96
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15255154
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.5
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1388000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	14762090
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.65
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1272000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10554140
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.5
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M12D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	217000	usd
CY2023Q4	omer	Common Stock Shares Outstanding Above Period End Closing Price CommonStockSharesOutstandingAbovePeriodEndClosingPrice	12300000
CY2023Q4	us-gaap	Share Price SharePrice	3.27
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7800000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4700000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	462000	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	3952000	usd
CY2021	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	1006000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	95183000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	85887000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	92837000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	78992000	usd
CY2023Q4	omer	Deferred Tax Asset Research And Development Capitalization DeferredTaxAssetResearchAndDevelopmentCapitalization	39318000	usd
CY2022Q4	omer	Deferred Tax Asset Research And Development Capitalization DeferredTaxAssetResearchAndDevelopmentCapitalization	21864000	usd
CY2023Q4	omer	Deferred Tax Assets Royalty Obligation DeferredTaxAssetsRoyaltyObligation	28903000	usd
CY2022Q4	omer	Deferred Tax Assets Royalty Obligation DeferredTaxAssetsRoyaltyObligation	28938000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10132000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12517000	usd
CY2023Q4	omer	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	5085000	usd
CY2022Q4	omer	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	5926000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	10283000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	9234000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	281741000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	243358000	usd
CY2023Q4	omer	Deferred Tax Liabilities Gain On Discontinued Operation DeferredTaxLiabilitiesGainOnDiscontinuedOperation	38832000	usd
CY2022Q4	omer	Deferred Tax Liabilities Gain On Discontinued Operation DeferredTaxLiabilitiesGainOnDiscontinuedOperation	34883000	usd
CY2023Q4	omer	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	4304000	usd
CY2022Q4	omer	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	4987000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	122000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	288000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	43258000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	40158000	usd
CY2023Q4	omer	Deferred Tax Assets Liabilities Net Before Valuation Allowance DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance	238483000	usd
CY2022Q4	omer	Deferred Tax Assets Liabilities Net Before Valuation Allowance DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance	203200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	238483000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	203200000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.021	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.017	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.006	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.277	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.283	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.269	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.08	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.068	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.055	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.015	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.014	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.003	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.019	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	200000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	300000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1800000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	212000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1796000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	30000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	12000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1966000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	800000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.04	pure
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	4000	usd

Files In Submission

Name	View Source	Status
0001437749-24-010416-index-headers.html	Edgar Link	pending
0001437749-24-010416-index.html	Edgar Link	pending
0001437749-24-010416.txt	Edgar Link	pending
0001437749-24-010416-xbrl.zip	Edgar Link	pending
ex_566808.htm	Edgar Link	pending
ex_566809.htm	Edgar Link	pending
ex_566810.htm	Edgar Link	pending
ex_566811.htm	Edgar Link	pending
ex_566812.htm	Edgar Link	pending
ex_630461.htm	Edgar Link	pending
ex_630463.htm	Edgar Link	pending
ex_630464.htm	Edgar Link	pending
ex_630465.htm	Edgar Link	pending
ex_630468.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
omer-20231231.xsd	Edgar Link	pending
omer20231231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
omer-20231231_cal.xml	Edgar Link	unprocessable
omer-20231231_def.xml	Edgar Link	unprocessable
omer-20231231_lab.xml	Edgar Link	unprocessable
omer-20231231_pre.xml	Edgar Link	unprocessable
omer20231231_10k_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stockpricegraph.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OMER
OMEROS CORP Stock $omer

2024 Q1 Form 10-K Financial Statement

#000143774924010416 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER OMEROS CORP Stock $omer

2024 Q1 Form 10-K Financial Statement

#000143774924010416 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER
OMEROS CORP Stock $omer